Catherine Pugliese‐Sivo

SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection<i>in vitro</i>and<i>in vivo</i>

Julie Strizki, Serena Xu, Nicole Wagner et al. · Proceedings of the National Academy of Sciences · 2001 · 300 citations · Full text

Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1

Julie Strizki, Cécile Tremblay, Serena Xu et al. · Antimicrobial Agents and Chemotherapy · 2005 · 214 citations · Full text

Antiviral Compound, Neurovirology, Medicine +15

Inhibition of the development of collagen‐induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5

Michel Vierboom, Paul J. Zavodny, Chuan‐Chu Chou et al. · Arthritis & Rheumatism · 2005 · 92 citations

HUMAN B CELL-ATTRACTING CHEMOKINE 1 (BCA-1; CXCL13) IS AN AGONIST FOR THE HUMAN CXCR3 RECEPTOR

Chung-Her Jenh, Mary Ann Cox, William Hipkin et al. · Cytokine · 2001 · 91 citations

Immunology, Receptor (Biochemistry), Immunologic Mechanism +4

Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice

Eva‐Pia Reich, Long Cui, Lily Yang et al. · European Journal of Immunology · 2005 · 87 citations

T-regulatory Cell, Immunology, Immune Regulation +19